APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood Plasma Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchBlood Plasma Derivatives Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Derivatives Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Blood Plasma Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Derivatives Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Derivatives Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Blood Plasma Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Blood Plasma Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Plasma Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Plasma Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood Plasma Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Plasma Derivatives include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Blood Plasma Derivatives market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Plasma Derivatives and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Plasma Derivatives revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Blood Plasma Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Plasma Derivatives Segment by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Octapharma

LFB Group

KM Biologics

Kedrion

Grifols

CSL

BPL

Biotest

Blood Plasma Derivatives Segment by Type

Albumin

Coagulation Factor

Immune Globulin

Other

Blood Plasma Derivatives Segment by Application

Hospital

Retail Pharmacy

Other

Blood Plasma Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blood Plasma Derivatives in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Plasma Derivatives industry.

Chapter 3: Detailed analysis of Blood Plasma Derivatives companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Plasma Derivativesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Albumin Table 3. Key Players of Coagulation Factor Table 4. Key Players of Immune Globulin Table 3. Key Players of Other Table 4. Global Blood Plasma Derivatives Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Blood Plasma Derivatives Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Blood Plasma Derivatives Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Blood Plasma Derivatives Market Share by Region (2021-2026) Table 11. Global Blood Plasma Derivatives Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Blood Plasma Derivatives Market Share by Region (2027-2032) Table 13. Blood Plasma Derivatives Industry Trends Table 14. Blood Plasma Derivatives Industry Drivers Table 15. Blood Plasma Derivatives Industry Opportunities and Challenges Table 16. Blood Plasma Derivatives Industry Restraints Table 17. Global Blood Plasma Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Blood Plasma Derivatives Revenue Market Share by Company (2021-2026) Table 19. Global Blood Plasma Derivatives Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Blood Plasma Derivatives Key Company Head Office and Area Served Table 21. Global Blood Plasma Derivatives Company, Product Type & Application Table 22. Global Blood Plasma Derivatives Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Blood Plasma Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Blood Plasma Derivatives Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2021-2026) Table 29. Global Blood Plasma Derivatives Revenue Market Share by Type (2027-2032) Table 30. Global Blood Plasma Derivatives Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Blood Plasma Derivatives Revenue Market Share by Application (2021-2026) Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2027-2032) Table 35. Yuanda Shuyang Company Information Table 36. Yuanda Shuyang Business Overview Table 37. Yuanda Shuyang Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Yuanda Shuyang Blood Plasma Derivatives Product Portfolio Table 39. Yuanda Shuyang Recent Development Table 40. Takeda Company Information Table 41. Takeda Business Overview Table 42. Takeda Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Takeda Blood Plasma Derivatives Product Portfolio Table 44. Takeda Recent Development Table 45. Weiguang Bio Company Information Table 46. Weiguang Bio Business Overview Table 47. Weiguang Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Weiguang Bio Blood Plasma Derivatives Product Portfolio Table 49. Weiguang Bio Recent Development Table 50. Tiantan Bio Company Information Table 51. Tiantan Bio Business Overview Table 52. Tiantan Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Tiantan Bio Blood Plasma Derivatives Product Portfolio Table 54. Tiantan Bio Recent Development Table 55. CBPO Company Information Table 56. CBPO Business Overview Table 57. CBPO Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. CBPO Blood Plasma Derivatives Product Portfolio Table 59. CBPO Recent Development Table 60. Shuanglin Bio Company Information Table 61. Shuanglin Bio Business Overview Table 62. Shuanglin Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shuanglin Bio Blood Plasma Derivatives Product Portfolio Table 64. Shuanglin Bio Recent Development Table 65. RAAS Company Information Table 66. RAAS Business Overview Table 67. RAAS Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. RAAS Blood Plasma Derivatives Product Portfolio Table 69. RAAS Recent Development Table 70. Nanyue Bio Company Information Table 71. Nanyue Bio Business Overview Table 72. Nanyue Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nanyue Bio Blood Plasma Derivatives Product Portfolio Table 74. Nanyue Bio Recent Development Table 75. Hualan Bio Company Information Table 76. Hualan Bio Business Overview Table 77. Hualan Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Hualan Bio Blood Plasma Derivatives Product Portfolio Table 79. Hualan Bio Recent Development Table 80. Boya Bio Company Information Table 81. Boya Bio Business Overview Table 82. Boya Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Boya Bio Blood Plasma Derivatives Product Portfolio Table 84. Boya Bio Recent Development Table 85. Octapharma Company Information Table 86. Octapharma Business Overview Table 87. Octapharma Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Octapharma Blood Plasma Derivatives Product Portfolio Table 89. Octapharma Recent Development Table 90. LFB Group Company Information Table 91. LFB Group Business Overview Table 92. LFB Group Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. LFB Group Blood Plasma Derivatives Product Portfolio Table 94. LFB Group Recent Development Table 95. KM Biologics Company Information Table 96. KM Biologics Business Overview Table 97. KM Biologics Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. KM Biologics Blood Plasma Derivatives Product Portfolio Table 99. KM Biologics Recent Development Table 100. Kedrion Company Information Table 101. Kedrion Business Overview Table 102. Kedrion Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Kedrion Blood Plasma Derivatives Product Portfolio Table 104. Kedrion Recent Development Table 105. Grifols Company Information Table 106. Grifols Business Overview Table 107. Grifols Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Grifols Blood Plasma Derivatives Product Portfolio Table 109. Grifols Recent Development Table 110. CSL Company Information Table 111. CSL Business Overview Table 112. CSL Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. CSL Blood Plasma Derivatives Product Portfolio Table 114. CSL Recent Development Table 115. BPL Company Information Table 116. BPL Business Overview Table 117. BPL Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. BPL Blood Plasma Derivatives Product Portfolio Table 119. BPL Recent Development Table 120. Biotest Company Information Table 121. Biotest Business Overview Table 122. Biotest Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Biotest Blood Plasma Derivatives Product Portfolio Table 124. Biotest Recent Development Table 125. North America Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Blood Plasma Derivatives Market Size by Country (2021-2026) Table 131. North America Blood Plasma Derivatives Market Size by Country (2027-2032) Table 132. Europe Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Blood Plasma Derivatives Market Size by Country (2021-2026) Table 138. Europe Blood Plasma Derivatives Market Size by Country (2027-2032) Table 139. China Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 140. China Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 141. China Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 142. China Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Blood Plasma Derivatives Market Size by Country (2021-2026) Table 149. Asia Blood Plasma Derivatives Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Blood Plasma Derivatives Product Image Figure 2. Global Blood Plasma Derivatives Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Blood Plasma Derivatives Market Share by Type: 2025 VS 2032 Figure 4. Albumin Image Figure 5. Coagulation Factor Image Figure 6. Immune Globulin Image Figure 7. Other Image Figure 8. Global Blood Plasma Derivatives Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Blood Plasma Derivatives Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Blood Plasma Derivatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 15. Global Blood Plasma Derivatives Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Blood Plasma Derivatives Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Blood Plasma Derivatives Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Blood Plasma Derivatives Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Blood Plasma Derivatives Revenue Market Share by Type (2021-2032) Figure 22. Global Blood Plasma Derivatives Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Blood Plasma Derivatives Revenue Market Share by Application (2021-2032) Figure 24. North America Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 25. North America Blood Plasma Derivatives Market Share by Type (2021-2032) Figure 26. North America Blood Plasma Derivatives Market Share by Application (2021-2032) Figure 27. North America Blood Plasma Derivatives Market Share by Country (2021-2032) Figure 28. United States Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 29. Canada Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 31. Europe Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 32. Europe Blood Plasma Derivatives Market Share by Type (2021-2032) Figure 33. Europe Blood Plasma Derivatives Market Share by Application (2021-2032) Figure 34. Europe Blood Plasma Derivatives Market Share by Country (2021-2032) Figure 35. Germany Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 36. France Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 38. Italy Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 39. Russia Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 41. China Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 42. China Blood Plasma Derivatives Market Share by Type (2021-2032) Figure 43. China Blood Plasma Derivatives Market Share by Application (2021-2032) Figure 44. Asia Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 45. Asia Blood Plasma Derivatives Market Share by Type (2021-2032) Figure 46. Asia Blood Plasma Derivatives Market Share by Application (2021-2032) Figure 47. Asia Blood Plasma Derivatives Market Share by Country (2021-2032) Figure 48. Japan Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 52. India Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 53. Australia Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Blood Plasma Derivatives Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Blood Plasma Derivatives Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Blood Plasma Derivatives Market Share by Country (2021-2032) Figure 58. Brazil Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 63. UAE Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 65. Chile Blood Plasma Derivatives Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Coagulation Factor
  • Immune Globulin
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • CBPO
  • Shuanglin Bio
  • RAAS
  • Nanyue Bio
  • Hualan Bio
  • Boya Bio
  • Octapharma
  • LFB Group
  • KM Biologics
  • Kedrion
  • Grifols
  • CSL
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Albumin
  5. 1.2.3 Coagulation Factor
  6. 1.2.4 Immune Globulin
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Blood Plasma Derivatives Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Blood Plasma Derivatives Growth Trends by Region
  15. 1.5.1 Global Blood Plasma Derivatives Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Blood Plasma Derivatives Market Size by Region (2021-2026)
  17. 1.5.3 Blood Plasma Derivatives Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Blood Plasma Derivatives Market Dynamics
  1. 2.1 Blood Plasma Derivatives Industry Trends
  2. 2.2 Blood Plasma Derivatives Industry Drivers
  3. 2.3 Blood Plasma Derivatives Industry Opportunities and Challenges
  4. 2.4 Blood Plasma Derivatives Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Blood Plasma Derivatives Revenue by Company (2021-2026)
  2. 3.2 Global Blood Plasma Derivatives Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Blood Plasma Derivatives Key Company Head office and Area Served
  4. 3.4 Global Blood Plasma Derivatives Company, Product Type & Application
  5. 3.5 Global Blood Plasma Derivatives Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Blood Plasma Derivatives Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Blood Plasma Derivatives Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Blood Plasma Derivatives Tier 1, Tier 2, and Tier 3
4 Blood Plasma Derivatives Market by Type
  1. 4.1 Global Blood Plasma Derivatives Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Blood Plasma Derivatives Market Size by Type (2021-2032)
  3. 4.3 Global Blood Plasma Derivatives Market Size Share by Type (2021-2032)
5 Blood Plasma Derivatives Market by Application
  1. 5.1 Global Blood Plasma Derivatives Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Blood Plasma Derivatives Market Size by Application (2021-2032)
  3. 5.3 Global Blood Plasma Derivatives Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Yuanda Shuyang
  2. 6.1.1 Yuanda Shuyang Company Information
  3. 6.1.2 Yuanda Shuyang Business Overview
  4. 6.1.3 Yuanda Shuyang Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Yuanda Shuyang Blood Plasma Derivatives Product Portfolio
  6. 6.1.5 Yuanda Shuyang Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Takeda Blood Plasma Derivatives Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Weiguang Bio
  14. 6.3.1 Weiguang Bio Company Information
  15. 6.3.2 Weiguang Bio Business Overview
  16. 6.3.3 Weiguang Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Weiguang Bio Blood Plasma Derivatives Product Portfolio
  18. 6.3.5 Weiguang Bio Recent Developments
  19. 6.4 Tiantan Bio
  20. 6.4.1 Tiantan Bio Company Information
  21. 6.4.2 Tiantan Bio Business Overview
  22. 6.4.3 Tiantan Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Tiantan Bio Blood Plasma Derivatives Product Portfolio
  24. 6.4.5 Tiantan Bio Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 CBPO Blood Plasma Derivatives Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Shuanglin Bio
  32. 6.6.1 Shuanglin Bio Company Information
  33. 6.6.2 Shuanglin Bio Business Overview
  34. 6.6.3 Shuanglin Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shuanglin Bio Blood Plasma Derivatives Product Portfolio
  36. 6.6.5 Shuanglin Bio Recent Developments
  37. 6.7 RAAS
  38. 6.7.1 RAAS Company Information
  39. 6.7.2 RAAS Business Overview
  40. 6.7.3 RAAS Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RAAS Blood Plasma Derivatives Product Portfolio
  42. 6.7.5 RAAS Recent Developments
  43. 6.8 Nanyue Bio
  44. 6.8.1 Nanyue Bio Company Information
  45. 6.8.2 Nanyue Bio Business Overview
  46. 6.8.3 Nanyue Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Nanyue Bio Blood Plasma Derivatives Product Portfolio
  48. 6.8.5 Nanyue Bio Recent Developments
  49. 6.9 Hualan Bio
  50. 6.9.1 Hualan Bio Company Information
  51. 6.9.2 Hualan Bio Business Overview
  52. 6.9.3 Hualan Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hualan Bio Blood Plasma Derivatives Product Portfolio
  54. 6.9.5 Hualan Bio Recent Developments
  55. 6.10 Boya Bio
  56. 6.10.1 Boya Bio Company Information
  57. 6.10.2 Boya Bio Business Overview
  58. 6.10.3 Boya Bio Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Boya Bio Blood Plasma Derivatives Product Portfolio
  60. 6.10.5 Boya Bio Recent Developments
  61. 6.11 Octapharma
  62. 6.11.1 Octapharma Company Information
  63. 6.11.2 Octapharma Business Overview
  64. 6.11.3 Octapharma Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Octapharma Blood Plasma Derivatives Product Portfolio
  66. 6.11.5 Octapharma Recent Developments
  67. 6.12 LFB Group
  68. 6.12.1 LFB Group Company Information
  69. 6.12.2 LFB Group Business Overview
  70. 6.12.3 LFB Group Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 LFB Group Blood Plasma Derivatives Product Portfolio
  72. 6.12.5 LFB Group Recent Developments
  73. 6.13 KM Biologics
  74. 6.13.1 KM Biologics Company Information
  75. 6.13.2 KM Biologics Business Overview
  76. 6.13.3 KM Biologics Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 KM Biologics Blood Plasma Derivatives Product Portfolio
  78. 6.13.5 KM Biologics Recent Developments
  79. 6.14 Kedrion
  80. 6.14.1 Kedrion Company Information
  81. 6.14.2 Kedrion Business Overview
  82. 6.14.3 Kedrion Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Kedrion Blood Plasma Derivatives Product Portfolio
  84. 6.14.5 Kedrion Recent Developments
  85. 6.15 Grifols
  86. 6.15.1 Grifols Company Information
  87. 6.15.2 Grifols Business Overview
  88. 6.15.3 Grifols Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Grifols Blood Plasma Derivatives Product Portfolio
  90. 6.15.5 Grifols Recent Developments
  91. 6.16 CSL
  92. 6.16.1 CSL Company Information
  93. 6.16.2 CSL Business Overview
  94. 6.16.3 CSL Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 CSL Blood Plasma Derivatives Product Portfolio
  96. 6.16.5 CSL Recent Developments
  97. 6.17 BPL
  98. 6.17.1 BPL Company Information
  99. 6.17.2 BPL Business Overview
  100. 6.17.3 BPL Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 BPL Blood Plasma Derivatives Product Portfolio
  102. 6.17.5 BPL Recent Developments
  103. 6.18 Biotest
  104. 6.18.1 Biotest Company Information
  105. 6.18.2 Biotest Business Overview
  106. 6.18.3 Biotest Blood Plasma Derivatives Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Biotest Blood Plasma Derivatives Product Portfolio
  108. 6.18.5 Biotest Recent Developments
7 North America
  1. 7.1 North America Blood Plasma Derivatives Market Size (2021-2032)
  2. 7.2 North America Blood Plasma Derivatives Market Size by Type
  3. 7.2.1 North America Blood Plasma Derivatives Market Size by Type (2021-2026)
  4. 7.2.2 North America Blood Plasma Derivatives Market Size by Type (2027-2032)
  5. 7.2.3 North America Blood Plasma Derivatives Market Share by Type (2021-2032)
  6. 7.3 North America Blood Plasma Derivatives Market Size by Application
  7. 7.3.1 North America Blood Plasma Derivatives Market Size by Application (2021-2026)
  8. 7.3.2 North America Blood Plasma Derivatives Market Size by Application (2027-2032)
  9. 7.3.3 North America Blood Plasma Derivatives Market Share by Application (2021-2032)
  10. 7.4 North America Blood Plasma Derivatives Market Size by Country
  11. 7.4.1 North America Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Blood Plasma Derivatives Market Size by Country (2021-2026)
  13. 7.4.3 North America Blood Plasma Derivatives Market Size by Country (2027-2032)
  14. 7.4.4 North America Blood Plasma Derivatives Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Blood Plasma Derivatives Market Size (2021-2032)
  2. 8.2 Europe Blood Plasma Derivatives Market Size by Type
  3. 8.2.1 Europe Blood Plasma Derivatives Market Size by Type (2021-2026)
  4. 8.2.2 Europe Blood Plasma Derivatives Market Size by Type (2027-2032)
  5. 8.2.3 Europe Blood Plasma Derivatives Market Share by Type (2021-2032)
  6. 8.3 Europe Blood Plasma Derivatives Market Size by Application
  7. 8.3.1 Europe Blood Plasma Derivatives Market Size by Application (2021-2026)
  8. 8.3.2 Europe Blood Plasma Derivatives Market Size by Application (2027-2032)
  9. 8.3.3 Europe Blood Plasma Derivatives Market Share by Application (2021-2032)
  10. 8.4 Europe Blood Plasma Derivatives Market Size by Country
  11. 8.4.1 Europe Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Blood Plasma Derivatives Market Size by Country (2021-2026)
  13. 8.4.3 Europe Blood Plasma Derivatives Market Size by Country (2027-2032)
  14. 8.4.4 Europe Blood Plasma Derivatives Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Blood Plasma Derivatives Market Size (2021-2032)
  2. 9.2 China Blood Plasma Derivatives Market Size by Type
  3. 9.2.1 China Blood Plasma Derivatives Market Size by Type (2021-2026)
  4. 9.2.2 China Blood Plasma Derivatives Market Size by Type (2027-2032)
  5. 9.2.3 China Blood Plasma Derivatives Market Share by Type (2021-2032)
  6. 9.3 China Blood Plasma Derivatives Market Size by Application
  7. 9.3.1 China Blood Plasma Derivatives Market Size by Application (2021-2026)
  8. 9.3.2 China Blood Plasma Derivatives Market Size by Application (2027-2032)
  9. 9.3.3 China Blood Plasma Derivatives Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Blood Plasma Derivatives Market Size (2021-2032)
  2. 10.2 Asia Blood Plasma Derivatives Market Size by Type
  3. 10.2.1 Asia Blood Plasma Derivatives Market Size by Type (2021-2026)
  4. 10.2.2 Asia Blood Plasma Derivatives Market Size by Type (2027-2032)
  5. 10.2.3 Asia Blood Plasma Derivatives Market Share by Type (2021-2032)
  6. 10.3 Asia Blood Plasma Derivatives Market Size by Application
  7. 10.3.1 Asia Blood Plasma Derivatives Market Size by Application (2021-2026)
  8. 10.3.2 Asia Blood Plasma Derivatives Market Size by Application (2027-2032)
  9. 10.3.3 Asia Blood Plasma Derivatives Market Share by Application (2021-2032)
  10. 10.4 Asia Blood Plasma Derivatives Market Size by Country
  11. 10.4.1 Asia Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Blood Plasma Derivatives Market Size by Country (2021-2026)
  13. 10.4.3 Asia Blood Plasma Derivatives Market Size by Country (2027-2032)
  14. 10.4.4 Asia Blood Plasma Derivatives Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Blood Plasma Derivatives Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Blood Plasma Derivatives Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Blood Plasma Derivatives Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Blood Plasma Derivatives Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Blood Plasma Derivatives Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst